Alembic Pharmaceuticals Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Mar '24
Dec '23
Sep '23
Jun '23
Mar '23
Total Qtr Revenue cr
1,520.58
1,633.46
1,605.09
1,497.81
1,407.34
Other Income Qtr Cr3.602.8910.1511.670.89
Operating Revenues Qtr1,516.981,630.571,594.931,486.151,406.45

*All values are in Cr.

Operating Expenses Qtr
1,256.92
1,364.21
1,386.69
1,287.46
1,194.23
Operating Profit Qtr
260.06
266.36
208.25
198.69
212.22
EBIDT Qtr Cr
263.66
269.25
218.40
210.36
213.11
Depreciation Qtr
69.48
69.45
67.56
66.18
74.12
Net Profit Qtr
178.21
180.45
136.56
120.60
152.60
Basic EPS Qtr
9.07
9.18
6.95
6.14
7.76
Open Demat Account
or Resume your Application
+91 -

personImage